Results 81 to 90 of about 1,347,749 (178)

IDO1 and FOXP3: Possible immune‐regulating genes alleviating cedar pollinosis via L. plantarum YIT 0132

open access: yes
Allergy, Volume 79, Issue 7, Page 1966-1969, July 2024.
Norihiro Kubota   +5 more
wiley   +1 more source

Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen

open access: yesAllergology International, 2015
Background: This study aims to examine the immunological parameters, focusing IL-10 productivity, in prophylactic sublingual immunotherapy (SLIT) in asymptomatic subjects sensitized to Japanese cedar pollen (JCP).
Kei-ichi Yamanaka   +6 more
doaj   +1 more source

Characteristics of patients tested for Japanese cedar pollinosis.

open access: yesPractica Oto-Rhino-Laryngologica, 1986
Allergy tests showed the following characteristics of patients with Japanese cedar pollinosis.1) Unlike patients with perennial allergy, many of those with Japanese cedar pollinosis were women above 20 years of age.2) Pollinosis patients had more severe symptoms than perennial allergy patients.
SAKAGUCHI, Kosaku   +2 more
openaire   +2 more sources

Analysis of factors influencing sensitization of Japanese cedar pollen in asymptomatic subjects [PDF]

open access: yes, 2014
三重大学博士(医学)application/pdfObjective: Japanese cedar pollinosis is increasing rapidly in Japan. Although analysis has been made concerning the factors influencing the development of the cedar pollinosis, analysis concerning the risk factors influencing the
サカイダ, ヒロシ   +2 more
core  

Allergic Potency of Japanese Cedar Pollen Cry j 1 Is Reduced by a Low Concentration of Hypochlorous Acid Generated by Electolysis

open access: yesAllergology International, 2009
Background: Although Japanese cedar (Cryptomeria japonica) pollinosis has developed into a health problem, few methods eradicate indoor allergens completely.
Tetsuya Terada   +5 more
doaj   +1 more source

Comparison of Regular and As-needed Use of Mometasone Furoate Hydrate Nasal Spray for the Treatment of Japanese Cedar Pollinosis

open access: yes, 2020
application/pdfBackground: Intranasal glucocorticosteroids (INSs) are the first-line treatment for allergic rhinitis. However, it is not clear whether regular use of INSs during the pollen season is necessary for patients with Japanese cedar pollinosis ...
MATSUOKA, Tomokazu   +5 more
core  

Anti-inflammatory roles of interleukin-35 in the pathogenesis of Japanese cedar pollinosis. [PDF]

open access: yesAsia Pac Allergy, 2021
Kouzaki H   +7 more
europepmc   +1 more source

Clinical Efficacy of Ramatroban on Japanese Cedar Pollinosis.

open access: yesPractica Oto-Rhino-Laryngologica, 2002
The clinical efficacy of ramatroban, a thromboxane A2 receptor antagonist, was investigated in 48 patients who consulted Masutani ENT Clinic in Osaka between January and May, 2001. Medication was administered and groups were stratified by start time.In the peak period for Japanese cedar pollen scattering, the pre-treatment group demonstrated better ...
MASUTANI, Haruhiko, WASHIO, Yushi
openaire   +2 more sources

Anti-IgE Antibody Therapy for Japanese Cedar Pollinosis: Omalizumab Update

open access: yesAllergology International, 2008
Seasonal allergic rhinitis (SAR) induced by Japanese cedar pollens is a substantial problem in Japan. Omalizumab, a novel humanized monoclonal anti-immunoglobulin E (IgE) antibody, has already been proven to reduce symptoms associated with SAR.
Kimihiro Okubo, Toshikazu Nagakura
doaj   +1 more source

Japanese Cedar Pollinosis in the South of Ibaraki Prefecture.

open access: yesPractica Oto-Rhino-Laryngologica, 2001
A clinical study of 1206 patients with Japanese cedar pollinosis treated between January 1975 and December 1999 was performed and in addition, the amount of Japanese cedar and cypress pollen in the south of Ibaraki Prefecture was measured every spring from 1981 to 1999 (19 years).The following findings were observed.1) The age distribution of Japanese ...
ARAI, Takashi, NAKAGAWA, Akiko
openaire   +2 more sources

Home - About - Disclaimer - Privacy